華富財經 Quamnet.com Logo
新聞
2020-09-16 14:37:48
CSPC PHARMA's new drug obtains clinical trial approval

(Infocast News) CSPC Pharmaceutical Group Limited (01093) announced that AlaMab Therapeutics (Shanghai) Inc., a subsidiary of the company, has obtained approval from the National Medical Products Administration of the PRC for conducting clinical trial of the investigational new drug ALMB-0168 for the treatment of bone cancer and bone metastasis in China.

(WL)